REGENERON PHARMACEUTICALS, INC.: cashflow_financing

Value{"amount": -2026800000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2026-01-01 – 2026-06-30
Statuscurrent
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000872589-26-000025
Retrieved: 2026-08-19T08:39:12.123968+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/cashflow-financing/2026-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/21ed4a7f-bb07-49e3-ae1b-55058dec4be0

History